Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Mirtazapine). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Mirtazapine is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.Use in children: Use in children are not recommended to Mirtazapine.Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.
Side Effects
The most common side effects of Mirez are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.
Cautions & Contraindications
Warnings & Precautions
Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirez should be warned about the risk of developing agranulocytosis. Mirez may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.
Contraindications
Hypersensitivity: Mirtazapine should not be used by anyone with a known hypersensitivity to Mirtazapine or to any of its excipients. Monoamine Oxidase Inhibitors: Mirtazapine must not be taken together with a monoamine oxidase (MAO) inhibitor. It should also be avoided within 14 days of starting or stopping treatment with an MAOI.